Health Condition 1: A159- Respiratory tuberculosis unspecified
Conditions
Interventions
Control Intervention1: Nil: Nil
Sponsors
Suvarna Swasthya Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals with signs and symptoms of Mycobacterial infection 2. Both males and females and transgender population are eligible for the study 3. Any age group subjects are eligible for the study. 4. All participants must be able to provide consent for themselves or have a parent/ guardian who can provide parental permission or have an authorized legal representative who can provide consent.
Exclusion criteria
Exclusion criteria: 1.Hostile or vulnerable patient group (e.g. prisoners and mentally retarded). 2.Patients who are unable to understand the study protocol or are unable to give informed consent or have no legal representative.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A registry can be used to educate healthcare providers about mycobacterial infections, improving awareness and understanding of these infections among clinicians. Data from the registry can help in developing personalized treatment plans based on the specific mycobacterial species and patient demographics.Timepoint: Ten years | — |
Secondary
| Measure | Time frame |
|---|---|
| For patients in whom, the standard therapy has failed, addition of Moxifloxacin could improve treatment outcomes. a clinical and laboratory registry for mycobacterial infections can significantly improve the diagnosis, treatment, and management of these infections, ultimately enhancing patient outcomes and public health in India Timepoint: Ten years | — |
Countries
India
Contacts
Public ContactVijay V Yeldandi
SSRC Health Clinics
Outcome results
None listed